David E. Lazar

David E. Lazar has an estimated net worth of $42 Million. This is based on reported shares across multiple companies, which include FiEE, Inc., TITAN PHARMACEUTICALS INC, OPGEN INC, Tracon Pharmaceuticals, Inc., LQR House Inc., KALA BIO, Inc., Cyclacel Pharmaceuticals, Inc., NovaBay Pharmaceuticals, Inc., Quantum Cyber N.V., Sow Good Inc., Aterian, Inc., and Indaptus Therapeutics, Inc..

2024 was David E. Lazar's most active year for acquiring shares with 10 total transactions. David E. Lazar's most active month to acquire stocks was the month of March. 2025 was David E. Lazar's most active year for disposing of shares, totalling 10 transactions. David E. Lazar's most active month to dispose stocks was the month of January. 2025 saw David E. Lazar paying a total of $3,000,000.00 for 206,816,820 shares, this is the most they've acquired in one year. In 2025 David E. Lazar cashed out on 203,660,143 shares for a total of $6,411,425.61, their largest year based on trade value.